tiprankstipranks
Trending News
More News >
Mabpharm Limited (HK:2181)
:2181
Hong Kong Market

Mabpharm Limited (2181) Income Statement

Compare
0 Followers

Mabpharm Limited Income Statement

Last quarter (Q4 2024), Mabpharm Limited's total revenue was ¥149.75M, an increase of 453.16% from the same quarter last year. In Q4, Mabpharm Limited's net income was ¥-30.38M. See Mabpharm Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 258.23M¥ 87.16M¥ 55.92M¥ 82.88M¥ 0.00
Gross Profit
¥ 219.39M¥ 75.24M¥ 40.54M¥ 66.11M¥ 0.00
Operating Expenses
¥ 329.71M¥ 277.22M¥ 239.76M¥ 350.76M¥ 163.43M
Depreciation and Amortization
¥ 51.86M¥ 60.70M¥ 51.55M¥ 43.88M¥ 16.28M
EBITDA
¥ -67.81M¥ -139.08M¥ -152.08M¥ -245.46M¥ -169.93M
Operating Income
¥ -119.67M¥ -201.98M¥ -203.83M¥ -289.27M¥ -180.69M
Other Income/Expenses
¥ -8.28M¥ -7.37M¥ -6.99M¥ -2.48M¥ -3.94M
Pretax Income
¥ -127.95M¥ -209.36M¥ -210.82M¥ -291.74M¥ -184.63M
Net Income
¥ -127.95M¥ -209.36M¥ -210.62M¥ -294.22M¥ -188.57M
Per Share Metrics
Basic EPS
¥ -0.03¥ -0.05¥ -0.05¥ -0.07¥ -0.05
Diluted EPS
¥ -0.03¥ -0.05¥ -0.05¥ -0.07¥ -0.05
Weighted Average Shares Outstanding
4.12B 4.12B 4.12B 4.12B 4.12B
Weighted Average Shares Outstanding (Diluted)
4.12B 4.12B 4.12B 4.12B 4.12B
Currency in CNY

Mabpharm Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis